Post #4: Travels to start-up city

Business trips to Tel Aviv are always enjoyable. Of course, there is the sun (apparently 300 days of it annually) and sea as well as some of the most impressive cuisine globally. But perhaps of most note is the fact that the city produces more start-ups per capita than any other in the world.

This ranking comes courtesy of the Global Start-up Ecosystem report published last year. What is interesting to us is both the breadth of sectors Israel’s start-ups span and, more importantly, why the country is able to produce so many dynamic businesses. Israeli companies capitalised at over US$15bn can be found in sectors as diverse as generic pharmaceuticals (Teva) and cybersecurity (Check Point). Many household names also began their life in the country before being acquired by larger corporations. Mobileye currently holds the title for the most lucrative acquisition of an Israeli business, given the US$15.3bn paid for it by Intel in 2017. Elsewhere, other large US corporates have acquired Israel organisations in fields including traffic management (Google’s purchase of Waze), robotics (Medtronic acquiring Mazor Robotics) and food innovation (IFF gaining control of Frutarom). 

Why is there such a strong start-up culture in the country? Some of it simply reflects a self-sustaining ecosystem of experienced investors and academics/ scientists and strong university programmes. The government has also played a notable role, reducing corporation tax for start-ups, removing bureaucratic hurdles and making a clear commitment almost to double the number of skilled personnel employed in the tech sector to 500,000 (or more than 5% of the population) during the next decade. We remain highly impressed by the entrepreneurial and international mentality of the people/businesses whom we meet from the country. Many more of the beneficiaries of the future trends which excite us look set to emerge from Israel in the coming years. Watch this space.

Disclaimers

The document is provided for information purposes only and does not constitute investment advice or any recommendation to buy, or sell or otherwise transact in any investments. The document is not intended to be construed as investment research. The contents of this document are based upon sources of information which Heptagon Capital believes to be reliable. However, except to the extent required by applicable law or regulations, no guarantee, warranty or representation (express or implied) is given as to the accuracy or completeness of this document or its contents and, Heptagon Capital, its affiliate companies and its members, officers, employees, agents and advisors do not accept any liability or responsibility in respect of the information or any views expressed herein. Opinions expressed whether in general or in both on the performance of individual investments and in a wider economic context represent the views of the contributor at the time of preparation. Where this document provides forward-looking statements which are based on relevant reports, current opinions, expectations and projections, actual results could differ materially from those anticipated in such statements. All opinions and estimates included in the document are subject to change without notice and Heptagon Capital is under no obligation to update or revise information contained in the document. Furthermore, Heptagon Capital disclaims any liability for any loss, damage, costs or expenses (including direct, indirect, special and consequential) howsoever arising which any person may suffer or incur as a result of viewing or utilising any information included in this document. 

The document is protected by copyright. The use of any trademarks and logos displayed in the document without Heptagon Capital's prior written consent is strictly prohibited. Information in the document must not be published or redistributed without Heptagon Capital's prior written consent. 

Heptagon Capital LLP, 63 Brook Street, Mayfair, London W1K 4HS
tel +44 20 7070 1800
fax +44 20 7070 1881
email [email protected] 

Partnership No: OC307355 Registered in England and Wales Authorised & Regulated by the Financial Conduct Authority 

Related Insights

Featured Insights
Featured Insights20 January 2021

Season 3, Post 3: Shop online, and help save the planet

Several times a day, it seems, the doorbell rings, the dog barks and yet another package is delivered to the Gunz household. This pattern – exacerbated under lockdown – is being repeated up and down the country and across much of the world. While the speed and convenience of online ordering is certainly desirable, a […]

Learn more
Featured Insights
Featured Insights15 January 2021

Season 3, Post 2: Hot topics in healthcare

The Westin St Francis hotel on Union Square in downtown San Francisco is normally where the great and good of the healthcare world descend during the second week of January. This year, of course, is far from normal and one of the industry’s largest conferences (organised by JP Morgan and now in its 39th year) […]

Learn more
Featured Insights
Featured Insights06 January 2021

Season 3, Post 1: The weird and wonderful

Welcome to 2021. Sign of the times perhaps, but the title for our opening Blog post of the year perhaps captures both our current and future assessment of the world. Uncertainty reigns as the pandemic rages, but this won’t stop dynamic innovation occurring across all industries. With the present so murky, what could be more […]

Learn more

Get The Updates

Separated they live in Bookmarks right at the coast of the famous Semantics, large language ocean Separated they live in Bookmarks right